Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
Recruiting · NCT06418061 · Registry updated 2025-01-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors | Locally Advanced or Metastatic Solid Tumors; Unresectable | Recruiting | Phase 1 | 2025-01-22 | NCT06418061 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Innovent Biologics (Suzhou) Co. Ltd. | 82 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shandong Cancer Hospital & Institute | Jinan | China | 3 |